China Biopharmaceutical Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Biopharmaceutical market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Biopharmaceutical market. Detailed analysis of key players, along with key growth strategies adopted by Biopharmaceutical industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Amgen

    • Johnson & Johnson

    • Eli Lilly

    • Roche

    • AbbVie

    • Novo Nordisk

    • Merck

    • Pfizer

    • Sanofi-Aventis

    • Novartis

    By Type:

    • Monoclonal Antibodies

    • Interferon

    • Erythropoietin

    • Insulin

    • Other

    By End-User:

    • Tumor

    • Diabetes

    • Cardiovascular

    • Hemophilia

    • Other

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biopharmaceutical Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Biopharmaceutical Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027

    • 1.3.2 China Biopharmaceutical Market Size and Growth Rate of Interferon from 2016 to 2027

    • 1.3.3 China Biopharmaceutical Market Size and Growth Rate of Erythropoietin from 2016 to 2027

    • 1.3.4 China Biopharmaceutical Market Size and Growth Rate of Insulin from 2016 to 2027

    • 1.3.5 China Biopharmaceutical Market Size and Growth Rate of Other from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Biopharmaceutical Market Size and Growth Rate of Tumor from 2016 to 2027

    • 1.4.2 China Biopharmaceutical Market Size and Growth Rate of Diabetes from 2016 to 2027

    • 1.4.3 China Biopharmaceutical Market Size and Growth Rate of Cardiovascular from 2016 to 2027

    • 1.4.4 China Biopharmaceutical Market Size and Growth Rate of Hemophilia from 2016 to 2027

    • 1.4.5 China Biopharmaceutical Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Biopharmaceutical Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biopharmaceutical by Major Types

    • 3.4.1 Market Size and Growth Rate of Monoclonal Antibodies

    • 3.4.2 Market Size and Growth Rate of Interferon

    • 3.4.3 Market Size and Growth Rate of Erythropoietin

    • 3.4.4 Market Size and Growth Rate of Insulin

    • 3.4.5 Market Size and Growth Rate of Other

    4 Segmentation of Biopharmaceutical Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biopharmaceutical by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Biopharmaceutical in Tumor

    • 4.4.2 Market Size and Growth Rate of Biopharmaceutical in Diabetes

    • 4.4.3 Market Size and Growth Rate of Biopharmaceutical in Cardiovascular

    • 4.4.4 Market Size and Growth Rate of Biopharmaceutical in Hemophilia

    • 4.4.5 Market Size and Growth Rate of Biopharmaceutical in Other

    5 Market Analysis by Regions

    • 5.1 China Biopharmaceutical Production Analysis by Regions

    • 5.2 China Biopharmaceutical Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Biopharmaceutical Landscape Analysis

    • 6.1 North China Biopharmaceutical Landscape Analysis by Major Types

    • 6.2 North China Biopharmaceutical Landscape Analysis by Major End-Users

    7 Central China Biopharmaceutical Landscape Analysis

    • 7.1 Central China Biopharmaceutical Landscape Analysis by Major Types

    • 7.2 Central China Biopharmaceutical Landscape Analysis by Major End-Users

    8 South China Biopharmaceutical Landscape Analysis

    • 8.1 South China Biopharmaceutical Landscape Analysis by Major Types

    • 8.2 South China Biopharmaceutical Landscape Analysis by Major End-Users

    9 East China Biopharmaceutical Landscape Analysis

    • 9.1 East China Biopharmaceutical Landscape Analysis by Major Types

    • 9.2 East China Biopharmaceutical Landscape Analysis by Major End-Users

    10 Northeast China Biopharmaceutical Landscape Analysis

    • 10.1 Northeast China Biopharmaceutical Landscape Analysis by Major Types

    • 10.2 Northeast China Biopharmaceutical Landscape Analysis by Major End-Users

    11 Southwest China Biopharmaceutical Landscape Analysis

    • 11.1 Southwest China Biopharmaceutical Landscape Analysis by Major Types

    • 11.2 Southwest China Biopharmaceutical Landscape Analysis by Major End-Users

    12 Northwest China Biopharmaceutical Landscape Analysis

    • 12.1 Northwest China Biopharmaceutical Landscape Analysis by Major Types

    • 12.2 Northwest China Biopharmaceutical Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Amgen

      • 13.1.1 Amgen Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Johnson & Johnson

      • 13.2.1 Johnson & Johnson Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Eli Lilly

      • 13.3.1 Eli Lilly Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Roche

      • 13.4.1 Roche Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 AbbVie

      • 13.5.1 AbbVie Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Novo Nordisk

      • 13.6.1 Novo Nordisk Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Merck

      • 13.7.1 Merck Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Pfizer

      • 13.8.1 Pfizer Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Sanofi-Aventis

      • 13.9.1 Sanofi-Aventis Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Novartis

      • 13.10.1 Novartis Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Biopharmaceutical Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027

    • Figure China Biopharmaceutical Market Size and Growth Rate of Interferon from 2016 to 2027

    • Figure China Biopharmaceutical Market Size and Growth Rate of Erythropoietin from 2016 to 2027

    • Figure China Biopharmaceutical Market Size and Growth Rate of Insulin from 2016 to 2027

    • Figure China Biopharmaceutical Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Biopharmaceutical Market Size and Growth Rate of Tumor from 2016 to 2027

    • Figure China Biopharmaceutical Market Size and Growth Rate of Diabetes from 2016 to 2027

    • Figure China Biopharmaceutical Market Size and Growth Rate of Cardiovascular from 2016 to 2027

    • Figure China Biopharmaceutical Market Size and Growth Rate of Hemophilia from 2016 to 2027

    • Figure China Biopharmaceutical Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Biopharmaceutical Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Biopharmaceutical Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Biopharmaceutical

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biopharmaceutical by Different Types from 2016 to 2027

    • Table Consumption Share of Biopharmaceutical by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Monoclonal Antibodies

    • Figure Market Size and Growth Rate of Interferon

    • Figure Market Size and Growth Rate of Erythropoietin

    • Figure Market Size and Growth Rate of Insulin

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Biopharmaceutical by Different End-Users from 2016 to 2027

    • Table Consumption Share of Biopharmaceutical by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Tumor

    • Figure Market Size and Growth Rate of Diabetes

    • Figure Market Size and Growth Rate of Cardiovascular

    • Figure Market Size and Growth Rate of Hemophilia

    • Figure Market Size and Growth Rate of Other

    • Table China Biopharmaceutical Production by Regions

    • Table China Biopharmaceutical Production Share by Regions

    • Figure China Biopharmaceutical Production Share by Regions in 2016

    • Figure China Biopharmaceutical Production Share by Regions in 2021

    • Figure China Biopharmaceutical Production Share by Regions in 2027

    • Table China Biopharmaceutical Consumption by Regions

    • Table China Biopharmaceutical Consumption Share by Regions

    • Figure China Biopharmaceutical Consumption Share by Regions in 2016

    • Figure China Biopharmaceutical Consumption Share by Regions in 2021

    • Figure China Biopharmaceutical Consumption Share by Regions in 2027

    • Table North China Biopharmaceutical Consumption by Types from 2016 to 2027

    • Table North China Biopharmaceutical Consumption Share by Types from 2016 to 2027

    • Figure North China Biopharmaceutical Consumption Share by Types in 2016

    • Figure North China Biopharmaceutical Consumption Share by Types in 2021

    • Figure North China Biopharmaceutical Consumption Share by Types in 2027

    • Table North China Biopharmaceutical Consumption by End-Users from 2016 to 2027

    • Table North China Biopharmaceutical Consumption Share by End-Users from 2016 to 2027

    • Figure North China Biopharmaceutical Consumption Share by End-Users in 2016

    • Figure North China Biopharmaceutical Consumption Share by End-Users in 2021

    • Figure North China Biopharmaceutical Consumption Share by End-Users in 2027

    • Table Central China Biopharmaceutical Consumption by Types from 2016 to 2027

    • Table Central China Biopharmaceutical Consumption Share by Types from 2016 to 2027

    • Figure Central China Biopharmaceutical Consumption Share by Types in 2016

    • Figure Central China Biopharmaceutical Consumption Share by Types in 2021

    • Figure Central China Biopharmaceutical Consumption Share by Types in 2027

    • Table Central China Biopharmaceutical Consumption by End-Users from 2016 to 2027

    • Table Central China Biopharmaceutical Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Biopharmaceutical Consumption Share by End-Users in 2016

    • Figure Central China Biopharmaceutical Consumption Share by End-Users in 2021

    • Figure Central China Biopharmaceutical Consumption Share by End-Users in 2027

    • Table South China Biopharmaceutical Consumption by Types from 2016 to 2027

    • Table South China Biopharmaceutical Consumption Share by Types from 2016 to 2027

    • Figure South China Biopharmaceutical Consumption Share by Types in 2016

    • Figure South China Biopharmaceutical Consumption Share by Types in 2021

    • Figure South China Biopharmaceutical Consumption Share by Types in 2027

    • Table South China Biopharmaceutical Consumption by End-Users from 2016 to 2027

    • Table South China Biopharmaceutical Consumption Share by End-Users from 2016 to 2027

    • Figure South China Biopharmaceutical Consumption Share by End-Users in 2016

    • Figure South China Biopharmaceutical Consumption Share by End-Users in 2021

    • Figure South China Biopharmaceutical Consumption Share by End-Users in 2027

    • Table East China Biopharmaceutical Consumption by Types from 2016 to 2027

    • Table East China Biopharmaceutical Consumption Share by Types from 2016 to 2027

    • Figure East China Biopharmaceutical Consumption Share by Types in 2016

    • Figure East China Biopharmaceutical Consumption Share by Types in 2021

    • Figure East China Biopharmaceutical Consumption Share by Types in 2027

    • Table East China Biopharmaceutical Consumption by End-Users from 2016 to 2027

    • Table East China Biopharmaceutical Consumption Share by End-Users from 2016 to 2027

    • Figure East China Biopharmaceutical Consumption Share by End-Users in 2016

    • Figure East China Biopharmaceutical Consumption Share by End-Users in 2021

    • Figure East China Biopharmaceutical Consumption Share by End-Users in 2027

    • Table Northeast China Biopharmaceutical Consumption by Types from 2016 to 2027

    • Table Northeast China Biopharmaceutical Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Biopharmaceutical Consumption Share by Types in 2016

    • Figure Northeast China Biopharmaceutical Consumption Share by Types in 2021

    • Figure Northeast China Biopharmaceutical Consumption Share by Types in 2027

    • Table Northeast China Biopharmaceutical Consumption by End-Users from 2016 to 2027

    • Table Northeast China Biopharmaceutical Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Biopharmaceutical Consumption Share by End-Users in 2016

    • Figure Northeast China Biopharmaceutical Consumption Share by End-Users in 2021

    • Figure Northeast China Biopharmaceutical Consumption Share by End-Users in 2027

    • Table Southwest China Biopharmaceutical Consumption by Types from 2016 to 2027

    • Table Southwest China Biopharmaceutical Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Biopharmaceutical Consumption Share by Types in 2016

    • Figure Southwest China Biopharmaceutical Consumption Share by Types in 2021

    • Figure Southwest China Biopharmaceutical Consumption Share by Types in 2027

    • Table Southwest China Biopharmaceutical Consumption by End-Users from 2016 to 2027

    • Table Southwest China Biopharmaceutical Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Biopharmaceutical Consumption Share by End-Users in 2016

    • Figure Southwest China Biopharmaceutical Consumption Share by End-Users in 2021

    • Figure Southwest China Biopharmaceutical Consumption Share by End-Users in 2027

    • Table Northwest China Biopharmaceutical Consumption by Types from 2016 to 2027

    • Table Northwest China Biopharmaceutical Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Biopharmaceutical Consumption Share by Types in 2016

    • Figure Northwest China Biopharmaceutical Consumption Share by Types in 2021

    • Figure Northwest China Biopharmaceutical Consumption Share by Types in 2027

    • Table Northwest China Biopharmaceutical Consumption by End-Users from 2016 to 2027

    • Table Northwest China Biopharmaceutical Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Biopharmaceutical Consumption Share by End-Users in 2016

    • Figure Northwest China Biopharmaceutical Consumption Share by End-Users in 2021

    • Figure Northwest China Biopharmaceutical Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of AbbVie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

    • Figure Sales and Growth Rate Analysis of AbbVie

    • Figure Revenue and Market Share Analysis of AbbVie

    • Table Product and Service Introduction of AbbVie

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Sanofi-Aventis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Aventis

    • Figure Sales and Growth Rate Analysis of Sanofi-Aventis

    • Figure Revenue and Market Share Analysis of Sanofi-Aventis

    • Table Product and Service Introduction of Sanofi-Aventis

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.